The M184V Substitution in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Delays the Development of Resistance to Amprenavir and Efavirenz in Subtype B and C Clinical Isolates

The M184V substitution in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT), encoding high-level resistance to lamivudine (3TC), results in decreased HIV-1 replicative capacity, diminished RT processivity, and increased RT fidelity in biochemical assays. We assessed the effect o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Diallo, Karidia, Brenner, Bluma, Oliveira, Maureen, Moisi, Daniela, Detorio, Mervi, Götte, Matthias, Wainberg, Mark A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2003
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC161854/
https://ncbi.nlm.nih.gov/pubmed/12821504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.7.2376-2379.2003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados